Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

12.13
Delayed Data
As of 4:00pm ET
 -0.01 / -0.08%
Today’s Change
10.52
Today|||52-Week Range
19.98
-1.14%
Year-to-Date
No recent news for Nektar Therapeutics.

Today’s Trading

Previous close12.14
Today’s open12.16
Day’s range11.69 - 12.28
Volume946,734
Average volume (3 months)1,655,408
Market cap$1.9B
Dividend yield--
Data as of 4:00pm ET, 01/24/2017

Growth & Valuation

Earnings growth (last year)-45.24%
Earnings growth (this year)-78.92%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+14.99%
P/E ratioNM
Price/Sales9.67
Price/Book255.47

Competitors

 Today’s
change
Today’s
% change
ONCESpark Therapeutics I...+0.76+1.32%
RDUSRadius Health Inc-1.42-3.34%
EXASExact Sciences Corp+0.04+0.20%
JUNOJuno Therapeutics In...+0.22+1.12%
Data as of 4:00pm ET, 01/24/2017

Financials

Next reporting dateMarch 7, 2017
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$230.8M
Annual profit (last year)-$81.2M
Net profit margin-35.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts


Search for Jobs